查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球生物技术原料市场 - 2023-2030年
市场调查报告书
商品编码
1297801

全球生物技术原料市场 - 2023-2030年

Global Biotech ingredients Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球生物技术原料市场在2022年达到566亿美元，预计到2030年将见证有利可图的增长，达到860亿美元。在预测期内（2023-2030年），全球生物技术原料市场预计将呈现5.5%的复合增长率。

近年来，由于各种趋势，如对天然和有机产品的需求上升，药物开发和治疗的进步，在个人护理和化妆品中的应用不断增加，农业生物技术的扩展，以及对可持续性和环境影响的关注，全球生物技术配料市场已大幅增长。

全球生物技术原料市场受到多种因素的驱动，如生物技术的进步、各行业采用的增加、个人护理和化妆品需求的增加以及消费者对可持续和天然产品需求的增加。例如，基因工程、合成生物学和生物加工等方面的进步，大大拓宽了生物技术物质的范围。

市场动态

个人护理和化妆品需求的增加推动了全球生物技术原料市场的增长

天然和有机产品在个人护理和化妆品领域的需求量很大，在其中使用生物技术成分将推动全球生物技术成分市场的发展。消费者越来越注意他们在皮肤和头发上使用的产品，他们正在寻找典型化妆品配方的天然和有机替代品。生物技术衍生的酶，如蛋白酶和脂肪酶，具有独特的品质，使它们适合用于护肤品。

例如，2022年4月，瑞典的一家生物技术企业Probi与全球配料供应商Symrise合作，为化妆品护肤品开发一种独特的后生物制剂。这种合作关系导致了SymFerment的诞生，这是一种非凡的回收成分，以Symrise品牌销售。

SymFerment是由乳酸菌发酵物创造的，这是一种从植物乳杆菌的发酵过程中获得的可持续副产品。由此产生的发酵液，也被称为上清液，具有适用于护肤品应用的特殊特性。它含有大量支持皮肤健康的微量营养素，如氨基酸、蛋白质、矿物质和有机酸。

食品和饮料行业越来越多的采用，推动了全球生物技术配料市场的增长。

食品和饮料行业越来越多地采用生物技术配料是由几个因素驱动的，包括需要提高食品质量、延长保质期和改善营养状况。消费者越来越多地寻找清洁标签和天然食品，这增加了对该领域生物技术成分的需求。

例如，2023年3月，位于加利福尼亚州的生物技术初创公司Shiru推出了其第一个市场产品OleoPro。这种新颖的产品是一种植物蛋白衍生的脂肪，旨在用于替代肉和其他基于植物的烹饪应用。Shiru公司开创性的Flourish技术平台产生了OleoPro，这是一种卓越的替代脂肪成分，结合了可持续性、高性能和营养价值。

技术和制造方面的挑战阻碍了市场的发展

生物技术配料的生产通常需要专门的基础设施、设备和经验，而这些可能并不常见或不容易获得。这些问题会对生产过程的可扩展性和成本效益产生影响。建立和维护专门的设施，如生物反应器、发酵罐或洁净室，可能是昂贵和费时的。

随着对生物技术部件需求的发展，扩大生产程序正变得越来越重要，但这可能是困难的。随着生产数量的扩大，保持稳定的产品质量、优化产量和保证可重复性变得更加困难。原材料、加工条件和生物系统的变化都会对产品的一致性产生影响，因此需要严格的质量控制程序。因此，由于上述因素，预计市场将在预测期内受到阻碍。

COVID-19影响分析

COVID-19大流行病对全球生物技术原料市场产生了巨大影响。对生物制药如疫苗和单克隆抗体的需求上升，提高了对用于配方的生物技术成分的需求。然而，供应链问题影响了成分的可用性。政府和组织集中精力提高疫苗制造能力，从而增加了需求。

监管的灵活性和快速审批促进了生物技术物质的及时供应。这场大流行引发了研究和开发倡议，强调了持续创新和投资生物技术元素的重要性，以解决新的健康问题。COVID-19对全球生物技术成分市场的长期影响仍在确定之中。

俄罗斯-乌克兰冲突分析

俄乌冲突有可能扰乱全球生物技术成分的供应链，特别是在受影响的国家。这可能会导致世界各地的生物技术原料的延迟或短缺。地缘政治的不确定性可能对生物技术行业的投资决策和公司运营产生影响，可能改变全球供应链。与战争有关的监管措施可能对贸易产生影响，并提高合规成本。

此外，市场信心和投资者情绪可能受到损害，从而损害生物技术行业的资金和投资。俄罗斯和乌克兰的区域生物技术成分市场可能会在业务连续性和进入国际市场方面遇到问题。持续的监测和灵活性对于利益相关者驾驭冲突对全球生物技术成分市场的影响至关重要。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按类型分析
  • 按产品分类
  • 按表达系统分类
  • 按地区分类

第四章：动态变化

  • 影响因素
    • 驱动因素
      • 对生物技术香精和香料成分的需求不断增加
      • 不断增长的技术进步
    • 限制因素
      • 由于对环境条件的要求，原材料的可用性有限
    • 机会
      • 对营养保健品的需求不断增加
    • 影响分析

第五章：行业分析

  • 波特的五力分析
  • 供应链分析
  • 未满足的需求
  • 监管分析

第六章：COVID-19分析

  • 对COVID-19的分析
    • COVID-19之前的情况
    • COVID-19期间的情况
    • COVID-19之后的情况
  • 在COVID-19期间的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结语

第7章 ：俄罗斯-乌克兰战争分析

第八章：按类型

  • 创新型生物技术原料药
  • 通用生物技术原料药/生物仿制药

第九章：按产品分类

  • 单克隆抗体
  • 疫苗
  • 细胞因子
  • 融合蛋白
  • 治疗性酶
  • 激素和生长因子
  • 血液因子
  • 其他

第十章：按表达系统分类

  • 微生物
  • 哺乳动物
  • 植物
  • 酵母
  • 昆虫
  • 其他

第十一章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第十二章 ：竞争格局

  • 竞争格局
  • 产品标杆
  • 公司份额分析
  • 主要发展和战略

第十三章 ：公司简介

  • Mylan, Inc.
    • 公司概述
    • 产品组合和描述
    • 财务概况
    • 主要发展情况
  • Pfizer, Inc.
  • Novartis AG
  • Sigma-Aldrich (Merck KGaA)
  • Bristol-Myers Squibb Company
  • Sanofi
  • Teva
  • AstraZeneca
  • BD
  • AbbVie Inc.

第十四章：附录

简介目录
Product Code: BT3068

Market Overview

The Global Biotech Ingredients Market reached US$ 56.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 86.0 billion by 2030. The global biotech ingredients market is expected to exhibit a CAGR of 5.5% during the forecast period (2023-2030).

The global biotech ingredients market has grown significantly in recent years, due to various trends such as rising demand for natural and organic products, advancements in drug development and therapies, growing application in personal care and cosmetics, expansion in agricultural biotechnology, and focus on sustainability and environmental impact.

The global biotech ingredients market is driven by multiple factors such as the advancements in biotechnology, increasing adoption across industries, increasing demand for personal care and cosmetics, and growing consumer demand for sustainable and natural products. For instance, the advancements such as genetic engineering, synthetic biology, and bioprocessing have considerably broadened the scope of biotech substances.

Market Dynamics

The Increasing Demand for Personal Care and Cosmetics is Propelling the Growth of the Global Biotech Ingredients Market

Natural and organic products are in high demand in the personal care and cosmetics sector, use of biotech ingredients in it will drive the global biotech ingredients market. Consumers are becoming more aware of the products they use on their skin and hair, and they are looking for natural and organic alternatives to typical cosmetic formulas. Biotechnology-derived enzymes, such as proteases and lipases, have unique qualities that make them appropriate for skincare products.

For instance, in April 2022, Probi, a Swedish biotech business, collaborated with Symrise, a global ingredient supplier, to develop a unique postbiotic for cosmetic skincare. This partnership resulted in the creation of SymFerment, an extraordinary recycled ingredient marketed under the Symrise brand.

SymFerment is created from Lactobacillus Ferment, a sustainable byproduct obtained from the fermentation process of the bacteria Lactiplantibacillus plantarum. The fermentation broth that results, also known as the supernatant, has exceptional properties that are suitable for skincare applications. It is high in micronutrients that support skin health, such as amino acids, proteins, minerals, and organic acids.

The Growing Adoption in Food and Beverage Industry is Driving the Growth of the Global Biotech ingredients Market

The growing adoption of biotech ingredients in the food and beverage industry is driven by several factors, including the need to enhance food quality, extend shelf life, and improve nutritional profiles. Consumers are increasingly looking for clean-label and natural food items, which has increased demand for biotech components in this area.

For instance, in March 2023, Shiru, a biotech startup based in California, launched its first market offering, OleoPro. This novel product is a plant protein-derived fat intended for substitute meat and other plant-based culinary applications. Shiru's pioneering Flourish technology platform yielded OleoPro, a superior alternative fat ingredient that combines sustainability, high performance, and nutritional value.

The Technical and Manufacturing Challenges is Hampering the Growth of the Market

Biotech ingredient production often requires specialized infrastructure, equipment, and experience that may not be commonly available or easily accessible. These issues can have an impact on the scalability and cost-effectiveness of manufacturing processes. Establishing and maintaining specialized facilities such as bioreactors, fermentation tanks, or cleanrooms can be costly and time-consuming.

Scaling up production procedures is becoming increasingly important as demand for biotech components develops, but it can be difficult. As production numbers expand, maintaining consistent product quality, optimizing yields, and assuring reproducibility become more difficult. Variations in raw materials, processing conditions, and biological systems can all have an impact on product consistency, necessitating stringent quality control procedures. Thus, owing to the above factors, the market is expected to hamper over the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic had a huge impact on the global biotech ingredients market. The rising demand for biopharmaceuticals such as vaccines and monoclonal antibodies raised the demand for biotech components used in the formulation. However, supply chain problems impacted ingredient availability. Governments and organizations concentrated on increasing vaccine manufacturing capacity, which increased demand.

Regulatory flexibility and quick approvals facilitated the timely availability of biotech substances. The pandemic sparked research and development initiatives, emphasizing the significance of continual innovation and investment in biotech elements to address new health concerns. The long-term impacts of COVID-19 on the global biotech ingredients market are still being determined.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict has the potential to disrupt global biotech ingredient supply chains, particularly in affected countries. This might cause biotech ingredient delays or shortages around the world. Geopolitical uncertainty may have an impact on investment decisions and company operations in the biotech industry, potentially changing the global supply chain. Regulatory measures relating to the war may have an impact on trade and raise compliance costs.

Moreover, market confidence and investor sentiment may be harmed, thereby hurting funding and investment in the biotech sector. Regional biotech ingredient markets in Russia and Ukraine may encounter problems in terms of business continuity and access to international markets. Continuous monitoring and flexibility are critical for stakeholders navigating the conflict's influence on the global biotech ingredients market.

Segment Analysis

The global biotech ingredients market is segmented based on type, product, expression system, end user, and region.

The Mammalian Expression System Segment is expected to hold a Dominant Position in the Global Biotech Ingredients Market over the Forecast Period.

The mammalian expression system segment is expected to hold 35.9% of market share for the global biotech ingredients market. Owing to the factors such as optimal protein functionality, complex biotech ingredient production, and downstream processing efficiency. Mammalian expression systems, which use mammalian cells, have distinct benefits for producing complex biotech ingredients, particularly therapeutic proteins and antibodies.

Moreover, many collaboration are ongoing for utilization of this mammalian expression system. For instance, in April 2022, Luzhu Biotech and Lonza, a global development and manufacturing partner to the pharmaceutical, biotech, and nutritional industries, have entered into a research and commercial license agreement for Luzhu to use Lonza's GS Xceed Gene Expression System with GS piggyBac transposon technology. Luzhu Biotech is a biopharmaceutical business dedicated to the discovery and development of novel therapeutic candidates for the prevention, control, and treatment of human diseases.

Geographical Analysis

North America Holds a Dominant Position in the Global Biotech Ingredients Market

North America is estimated to hold around 37.8% of the total market share throughout the forecast period, owing to the well-established healthcare infrastructure, favorable reimbursement policies, and presence of leading market players.

The United States is an example of North America's dominance. The country is a center for many biotech ingredient manufacturers as well as prominent research organizations. The headquarters of notable biotech businesses such as Amgen, Genentech, and Biogen are in the United States. These firms have played critical roles in the development and production of biotech ingredients, contributing to the market growth in North America.

Furthermore, renowned research institutions like as Massachusetts Institute of Technology (MIT) and University of California, San Francisco (UCSF) conduct pioneering research, driving innovation and bolstering North America's dominance in the global biotech ingredients market. Therefore, North America dominates the global biotech ingredients market with key companies, research infrastructure, and innovation focus.

Competitive Landscape

The major global players in the market include: Mylan, Inc., Pfizer, Inc., Novartis AG, Sigma-Aldrich (Merck KGaA), Bristol-Myers Squibb Company, Sanofi, Teva, AstraZeneca, BD, and AbbVie Inc., among others.

Why Purchase the Report?

  • To visualize the global biotech ingredients market segmentation based on the coating, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global biotech ingredients market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global biotech ingredients market report would provide approximately 49 tables, 53 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Product
  • 3.3. Snippet by Expression System
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Demand for Biotech Flavors and Fragrance Ingredients
      • 4.1.1.2. Growing Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Availability of Raw Materials 0wing to the Requirement of Ambient Conditions
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing Demand for Nutraceuticals
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By Type
  • 8.2. Innovative Biotech APIs*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Generic Biotech APIs/Biosimilar

9. By Product

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.1.2. Market Attractiveness Index, By Product
  • 9.2. Monoclonal Antibodies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Vaccines
  • 9.4. Cytokines
  • 9.5. Fusion Proteins
  • 9.6. Therapeutic Enzymes
  • 9.7. Hormones and Growth Factors
  • 9.8. Blood Factors
  • 9.9. Others

10. By Expression System

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
    • 10.1.2. Market Attractiveness Index, By Expression System
  • 10.2. Microbial*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Mammalian
  • 10.4. Plant
  • 10.5. Yeast
  • 10.6. Insect
  • 10.7. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1. The U.S.
      • 11.2.6.2. Canada
      • 11.2.6.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.6.1. Germany
      • 11.3.6.2. The U.K.
      • 11.3.6.3. France
      • 11.3.6.4. Italy
      • 11.3.6.5. Spain
      • 11.3.6.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.6.1. Brazil
      • 11.4.6.2. Argentina
      • 11.4.6.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.6.1. China
      • 11.5.6.2. India
      • 11.5.6.3. Japan
      • 11.5.6.4. Australia
      • 11.5.6.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Product Benchmarking
  • 12.3. Company Share Analysis
  • 12.4. Key Developments and Strategies

13. Company Profiles

  • 13.1. Mylan, Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Pfizer, Inc.
  • 13.3. Novartis AG
  • 13.4. Sigma-Aldrich (Merck KGaA)
  • 13.5. Bristol-Myers Squibb Company
  • 13.6. Sanofi
  • 13.7. Teva
  • 13.8. AstraZeneca
  • 13.9. BD
  • 13.10. AbbVie Inc.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us